Published on
December 16, 2025
- 13:00 GMT
MBX Capital Announces $100M to Power Biotech Startups Tackling Root Cause of Modern Disease
New capital will fund early-stage startups addressing the rise of chronic disease driven by environmental toxins and synthetic exposures NEW YORK, NY, UNITED STATES, December 16, 2025 /EINPresswire.com/ -- MBX Capital today announced it has crossed $100 …
Distribution channels:
Banking, Finance & Investment Industry
...
